Chemical Structure (Aciphex 01)
Aciphex Tablet, Delayed Release
Product Images NDC 80725-243
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Aciphex (NDC 80725-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Aciphex 02)
Figure 3 (Aciphex 03)
This is a study evaluating the mean scores of heartburn at different doses of RAB (10mg and 20mg) compared to a placebo. The heartburn scores range from 0 (none) to 4 (very severe). The study includes a total of 131 participants (64 in the 10mg group and 67 in the 20mg group). The graph represents the heartburn scores over a period of 28 days.*
Figure 4 (Aciphex 04)
Figure 5 (Aciphex 05)
This text provides information about a study evaluating the mean scores for two groups: "PLACEBO" (n=58) and "RAB20mg" (n=59). The study measures heartburn scores on a scale of 0 to 4, with 0 indicating no heartburn and 4 indicating very severe heartburn. Unfortunately, the specific mean scores are not available in the provided text.*
Principal Display Panel (30 Tablet Bottle Label)
This text appears to be a label or information regarding a medication called AcipHex. It provides dosing instructions and storage information. The medication is in the form of delayed-release tablets. It is distributed by Waylis Therapeutics LLC in Wicom, MI with an expiration date of 2023. The NDC (National Drug Code) for this medication is 80725-243-30.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
